Co-Authors
This is a "connection" page, showing publications co-authored by Pål Aukrust and Andreas Barratt-Due.
Connection Strength
0.749
-
Evaluation of the Effects of Remdesivir and Hydroxychloroquine on Viral Clearance in COVID-19 : A Randomized Trial. Ann Intern Med. 2021 09; 174(9):1261-1269.
Score: 0.239
-
How does COVID-19 affect the brain? Tidsskr Nor Laegeforen. 2020 06 30; 140(10).
Score: 0.221
-
Neutrophil count predicts clinical outcome in hospitalized COVID-19 patients: Results from the NOR-Solidarity trial. J Intern Med. 2022 02; 291(2):241-243.
Score: 0.061
-
Blood neurofilament light concentration at admittance: a potential prognostic marker in COVID-19. J Neurol. 2021 Oct; 268(10):3574-3583.
Score: 0.058
-
Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results. N Engl J Med. 2021 02 11; 384(6):497-511.
Score: 0.057
-
Elevated plasma sTIM-3 levels in patients with severe COVID-19. J Allergy Clin Immunol. 2021 01; 147(1):92-98.
Score: 0.056
-
Systemic complement activation is associated with respiratory failure in COVID-19 hospitalized patients. Proc Natl Acad Sci U S A. 2020 10 06; 117(40):25018-25025.
Score: 0.056